マイクロRNAに関する新しい研究は、より良い不妊治療につながる可能性がある(New study on microRNAs could lead to better fertility treatment)

ad

2024-10-16 カロリンスカ研究所(KI)

カロリンスカ研究所の研究者は、受精後の初期段階におけるヒト胚の細胞発達を制御する小さなRNA分子、特にmicroRNAの役割を解明しました。この研究は、受精卵が分裂して初期胚(胚盤胞)を形成する際に、どのsncRNAが重要かを示すアトラスを作成しました。これにより、体外受精(IVF)などの不妊治療において、健康な胚の識別が可能になり、治療の改善が期待されています。また、この発見は幹細胞治療や発生生物学の新たな研究への道を開くものです。

<関連情報>

ヒト着床前発生における低分子ノンコーディングRNAのアトラス An atlas of small non-coding RNAs in human preimplantation development

Stewart J. Russell,Cheng Zhao,Savana Biondic,Karen Menezes,Michael Hagemann-Jensen,Clifford L. Librach & Sophie Petropoulos
Nature Communications  Published:05 October 2024
DOI:https://doi.org/10.1038/s41467-024-52943-w

マイクロRNAに関する新しい研究は、より良い不妊治療につながる可能性がある(New study on microRNAs could lead to better fertility treatment)

Abstract

Understanding the molecular circuitries that govern early embryogenesis is important, yet our knowledge of these in human preimplantation development remains limited. Small non-coding RNAs (sncRNAs) can regulate gene expression and thus impact blastocyst formation, however, the expression of specific biotypes and their dynamics during preimplantation development remains unknown. Here we identify the abundance of and kinetics of piRNA, rRNA, snoRNA, tRNA, and miRNA from embryonic day (E)3-7 and isolate specific miRNAs and snoRNAs of particular importance in blastocyst formation and pluripotency. These sncRNAs correspond to specific genomic hotspots: an enrichment of the chromosome 19 miRNA cluster (C19MC) in the trophectoderm (TE), and the chromosome 14 miRNA cluster (C14MC) and MEG8-related snoRNAs in the inner cell mass (ICM), which may serve as ‘master regulators’ of potency and lineage. Additionally, we observe a developmental transition with 21 isomiRs and in tRNA fragment (tRF) codon usage and identify two novel miRNAs. Our analysis provides a comprehensive measure of sncRNA biotypes and their corresponding dynamics throughout human preimplantation development, providing an extensive resource. Better understanding the sncRNA regulatory programmes in human embryogenesis will inform strategies to improve embryo development and outcomes of assisted reproductive technologies. We anticipate broad usage of our data as a resource for studies aimed at understanding embryogenesis, optimising stem cell-based models, assisted reproductive technology, and stem cell biology.

細胞遺伝子工学
ad
ad
Follow
ad
タイトルとURLをコピーしました